Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 11/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.40 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | CCR3 | P51677 | 1/20 | 0.40 |
| ▸ | SUCNR1 | Q9BXA5 | 2/20 | 0.40 |
| ▸ | SSTR3 | P32745 | 2/20 | 0.39 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | TOP2A | P11388 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5583363 | 0.89 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5583534 | 0.84 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7264055 | 0.83 | ABCB11 (0.47) | SLC6A2SLC6A4SLC6A3CCR1ABCB11 | |
| SCHEMBL5583515 | 0.80 | LMNA (0.42) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5583488 | 0.79 | ABCB11 (0.46) | SLC6A2SLC6A4SLC6A3CCR1ABCB11 | |
| SCHEMBL7268791 | 0.78 | SLC6A2 (0.52) | SLC6A2SLC6A4SLC6A3CCR1ABCB11 | |
| SCHEMBL4509250 | 0.77 | ABCB11 (0.47) | SLC6A2SLC6A4SLC6A3ABCB11 | |
| SCHEMBL5583444 | 0.74 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3ABCB11 | |
| SCHEMBL3809661 | 0.73 | ABCB11 (0.68) | CCR1HRH1CCR3ABCB11KDM4E | |
| SCHEMBL5583417 | 0.73 | ABCB11 (0.48) | SLC6A2SLC6A4SLC6A3CCR1ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4022142-B2 | — | — | 2007-12-12 | — | — | JP | claimed |
| JP-2004507461-A | — | — | 2004-03-11 | — | — | JP | claimed |
| EP-1299357-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2003-04-09 | — | — | EP | claimed |
| WO-2001098273-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2001-12-27 | — | — | WO | claimed |
| EP-1299357-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2003-04-09 | — | — | EP | disclosed |
| WO-2001098273-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 2001-12-27 | — | — | WO | disclosed |